X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-24 | PRLD | Vaddi Krishna | CEO | P - Purchase | $5.15 | +1,900 | 2,715,145 | 0% | +$9,790 | |||||
2023-05-24 | PRLD | Lim Bryant David | GC, Corp Sec. | P - Purchase | $5.39 | +2,400 | 2,400 | New | +$12,936 | ||||||
2023-05-23 | PRLD | Chardonnet Laurent | CFO | P - Purchase | $5.50 | +5,000 | 42,165 | +13% | +$27,500 | ||||||
2023-05-23 | PRLD | Vaddi Krishna | CEO | P - Purchase | $5.63 | +11,856 | 2,713,245 | 0% | +$66,749 | ||||||
2023-05-22 | PRLD | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $5.75 | +869,565 | 10,646,056 | +9% | +$4,999,999 | ||||||
2023-05-22 | PRLD | Bonita David P | Dir, 10% | P - Purchase | $5.75 | +869,565 | 10,646,056 | +9% | +$4,999,999 | ||||||
| D | 2023-04-06 | PRLD | Huang Jane | Pres, CMO | S - Sale+OE | $6.12 | -13,280 | 24,220 | -35% | -$81,274 | |||||
2022-12-20 | PRLD | Vaddi Krishna | CEO | P - Purchase | $5.13 | +19,188 | 2,701,389 | +1% | +$98,446 | ||||||
2022-12-08 | PRLD | Chardonnet Laurent | CFO | P - Purchase | $4.76 | +10,000 | 35,873 | +39% | +$47,600 | ||||||
2022-06-01 | PRLD | Chardonnet Laurent | CFO | P - Purchase | $4.23 | +10,000 | 24,500 | +69% | +$42,300 | ||||||
| D | 2021-12-15 | PRLD | Morosini Deborah | EVP, Chief of Clinical Affairs | S - Sale+OE | $13.00 | -28,751 | 444 | -98% | -$373,763 | |||||
| M | 2021-12-13 | PRLD | Combs Andrew | EVP, Head of Chemistry | P - Purchase | $11.86 | +8,000 | 268,380 | +3% | +$94,880 | |||||
| D | 2021-11-16 | PRLD | Morosini Deborah | EVP, Chief of Clinical Affairs | S - Sale+OE | $15.88 | -28,751 | 444 | -98% | -$456,532 | |||||
| D | 2021-10-05 | PRLD | Mauro David J | Chief Medical Officer | S - Sale+OE | $30.96 | -15,000 | 0 | -100% | -$464,350 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |